Skip to main content
  • About Us
  • News
  • Careers
  • Authorized Partners
  • Products
  • Conditions
  • Education & Events
  • Careers
  • News

First Patient in Europe Receives Implant of GORE® EXCLUDER® Conformable AAA Endoprosthesis with ACTIVE CONTROL System and Enrolls in Post-Market Registry

Investigator initiated EXCeL Registry will assess safety and abdominal aortic aneurysm treatment success in patients with challenging anatomies

Gore to Highlight Real-World Aortic Data at 45th Annual VEITHsymposium<sup>&reg;</sup>

Company shares findings from the Global Registry for Endovascular Aortic Treatment (GREAT), the largest industry-sponsored registry of aortic stent grafts

W. L. GORE & ASSOCIATES ANNOUNCES ENCOURAGING SIX-MONTH RESULTS WITH ITS NOVEL BIOSYNTHETIC TISSUE VALVE

At the American Heart Association Virtual Scientific Sessions 2020.

GORE REDUCE CLINICAL STUDY FIVE-YEAR RESULTS DEMONSTRATE THAT PFO CLOSURE WITH THE GORE® CARDIOFORM SEPTAL OCCLUDER PROVIDES SAFE LONG-TERM REDUCTION OF RECURRENT STROKE

FIVE-YEAR RESULTS OF THE GORE® EXCLUDER® ILIAC BRANCH ENDOPROSTHESIS PIVOTAL U.S. MULTICENTER STUDY CONFIRM SAFETY, EFFICACY AND DURABILITY

Gore Global Registry for Endovascular Aortic Treatment Completes Enrollment

Over 5,000 patients from 114 worldwide sites provide a unique perspective of real-world conditions

Gore Marks 20th Year on 100 Best Companies to Work For® List

Gore has appeared in every edition of the rankings, published annually in Fortune magazine. The company is among just 12 “Great Place to Work Legends” to hold this distinction.

Gore Announces First-in-Human Use of GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System for TEVAR

New delivery system provides controlled and predictable placement of Gore’s highly conformable and time-tested stent graft

GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion May Reduce Portal Hypertension Readmissions in Ongoing Study

 

Gore Completes Patient Enrollment in U.S. Pivotal Clinical Study of GORE® CARDIOFORM ASD Occluder

New addition to GORE® CARDIOFORM Occluder family is designed to treat larger atrial septal defects by adapting to the patient’s anatomy for a permanent and safe closure

Pagination

  • Load more

Residents of some states have the right to opt-out of the “sharing” or “selling” of their personal information. Gore does not "sell" the personal information of website users. Gore may "share" the personal information of website users, as standard advertising practice meant to offer you a more personalized service.

If you want to opt-out from Gore “sharing” your personal information, click on Opt-Out of Sharing to turn off the targeting cookies that we share with our advertising partners in order to provide you with personalized information. Disabling sharing will stop the use of cookies to targeted advertising but you may still see generic Gore ads.

Please note that your exercising of the rights outlined will have no adverse effect on the price and quality of our goods or services.

Opt-Out of Sharing

You Have Successfully Opted Out of the Sharing of Your Personal Information

Please note that if you clear your cookies and then use another device or browser, etc. your opt-out status is not transferred to the new device or browser.

  • Cookie Settings
  • Legal Information
  • Privacy Notice
  • Regulatory Information
  • Trademarks
  • Contact Us
  • Newsletter
  • Modern Slavery Statement
  • gore.com

Copyright © 2002-2025 | W. L. Gore & Associates, Inc. | Products listed may not be available in all markets.